Optas LLC’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,207
Closed -$263K 502
2025
Q4
$263K Sell
3,207
-3,315
-51% -$258K 0.04% 342
2025
Q3
$490K Buy
6,522
+3,479
+114% +$259K 0.08% 155
2025
Q2
$225K Buy
3,043
+326
+12% +$22.7K 0.04% 297
2025
Q1
$219K Sell
2,717
-220
-7% -$18.9K 0.04% 263
2024
Q4
$230K Buy
2,937
+298
+11% +$25.3K 0.05% 223
2024
Q3
$248K Buy
2,639
+69
+3% +$5.79K 0.06% 199
2024
Q2
$200K Sell
2,570
-21
-0.8% -$1.71K 0.05% 196
2024
Q1
$236K Sell
2,591
-2
-0.1% -$166 0.06% 169
2023
Q4
$200K Buy
+2,593
New +$182K 0.06% 177
2023
Q3
Sell
-2,674
Closed -$217K 187
2023
Q2
$217K Buy
2,674
+203
+8% +$16.2K 0.07% 149
2023
Q1
$203K Buy
+2,471
New +$176K 0.07% 153

Other funds holding GEHC

Optas LLC's GEHC Position: Q1 2026 in Review

Optas LLC sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 3,207 shares — an estimated $263K sold.

Optas LLC first reported a position in GEHC in Q1 2023 and held it in 11 quarters. The position peaked at $490K in Q3 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Optas LLC reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Optas LLC sold 3,207 GE HealthCare shares in Q1 2026, an estimated $263K.
  • Optas LLC first reported a position in GE HealthCare in Q1 2023 and held it in 11 quarters.
  • Optas LLC's GE HealthCare position peaked at $490K in Q3 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Optas LLC's 13F filing for Q1 2026, filed 27 Apr 2026.